Pubmed – serious events in randomized trials in adults

Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults:

https://pubmed.ncbi.nlm.nih.gov/36055877/

Results: Pfizer and Moderna mRNA COVID-19 vaccines were associated with an excess risk of serious adverse events of special interest of 10.1 and 15.1 per 10,000 vaccinated over placebo baselines of 17.6 and 42.2 (95 % CI -0.4 to 20.6 and -3.6 to 33.8), respectively.